Houston Methodist

Projects

Projects per year 2000 2013 2016 2018 2019 2020 2021 2022 2023 2024 2046

• 193 Not started
• 538 Active
• 826 Finished

Projects per year

Search results

• Not started

  Retrospective review of clinical outcomes of lower extremity revascularization in patients with peripheral arterial disease.

  Peden, E. K. (PI) & Rahimi, M. (Key Personnel)

  Project: Clinical Trial

• Pharmacokinetic Analysis of Once-Daily Everolimus and Extended-Release Tacrolimus in Renal Transplant Recipients (CRAD001AUS214T) (PO#3004249477)

  Gaber, A. O. (PI), Hobeika, M. J. (Key Personnel), Knight, R. J. (Key Personnel), Saharia, A. (Key Personnel) & Yi, S. (Key Personnel)

  Project: Clinical Trial

• Beamion BCGC-1: A Phase Ib dose escalation and Phase II dose optimization, randomized, open-label, multicenter trial of oral zongertinib (BI 1810631) in combination with intravenous trastuzumab deruxtecan (T-DXd) or in combination with intravenous trastuzumab emtansine (T-DM1) for treatment of patients with advanced HER2+ metastatic breast cancer (mBC) and metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma (mGEAC)

  Niravath, P. A. (PI), Abdelrahim, M. (Key Personnel), Chang, J. C. (Key Personnel), Heyne, K. (Key Personnel), Mai, H. P. (Key Personnel), Singh, M. (Key Personnel) & Sun, K. (Key Personnel)

  Project: Clinical Trial

• COMPILATIONS OF CLINICAL FINDINGS IN AMYOTROPHIC LATERAL SCLEROSIS

  Appel, S. H. (PI), Greene, E. P. (Key Personnel), Liao, B. (Key Personnel) & Shroff, S. (Key Personnel)

  Project: Clinical Trial

• The COVID-19 and Cancer Consortium CCC19 Registry

  Zhang, J. (PI) & Sun, K. (Key Personnel)

  Project: Clinical Trial

• A Pilot Study of Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention In Women At High Risk Of Breast Cancer

  Chang, J. C. (PI), Arentz, C. (Key Personnel), Niravath, P. A. (Key Personnel), Singh, M. (Key Personnel) & Templeton, S. (Key Personnel)

  Project: Clinical Trial

• Research Review of Peripheral artery disease

  Peden, E. K. (PI), Garami, Z. (Key Personnel), Le, L. (Key Personnel) & Rahimi, M. (Key Personnel)

  Project: Clinical Trial

• Retrospective review of major lower extremity limb loss

  Peden, E. K. (PI)

  Project: Clinical Trial

• CoreValve® Expanded

  Kleiman, N. (PI), Faza, N. (Key Personnel), Goel, S. (Key Personnel), Lawrie, G. M. (Key Personnel), Lin, C. H. (Key Personnel), Little, S. H. (Key Personnel), Reardon, M. J. (Key Personnel) & Volpi, J. J. (Key Personnel)

  Project: Clinical Trial

• IMAG-PRIMARY MR

  Shah, D. J. (PI), Al-Mallah, M. (Key Personnel), Chamsi-Pasha, M. A. (Key Personnel), El-Tallawi, C. (Key Personnel), Malahfji, M. (Key Personnel) & Nabi, F. (Key Personnel)

  Project: Clinical Trial

• Retrospective Review of Groin infections in Vascular and Cardiac patients

  Peden, E. K. (PI) & Rahimi, M. (Key Personnel)

  Project: Clinical Trial

• VAS-WRAPSODY Endovascular Stent Graft for Hemodialysis Patients Merit Medical

  Peden, E. K. (PI), Le, L. (Key Personnel) & Rahimi, M. (Key Personnel)

  Project: Clinical Trial

• Urethral bulking versus Midurethral Sling during prolapse surgery for stress urinary incontinence

  High, R. A. (PI), Antosh, D. (Key Personnel) & Rutledge, E. (Key Personnel)

  Project: Clinical Trial

• Higher neural changes in patients taking overactive bladder medications

  Khavari, R. (PI) & High, R. A. (Key Personnel)

  Project: Clinical Trial

• Sample and Data Collection for Hematologic disorders section, Houston Methodist Cancer Center

  Pingali, S. R. (PI), Ganguly, S. (Key Personnel), Heyne, K. (Key Personnel), Hu, C.-C. A. (Key Personnel), Jin, M. M. (Key Personnel), Rice, L. (Key Personnel), Shah, S. (Key Personnel), Yang, J. (Key Personnel), Yi, Q. (Key Personnel) & Zieske, A. W. (Key Personnel)

  Project: Clinical Trial

• Catheter Ablation Registry

  Valderrábano, M. (PI), Bhimaraj, A. (Key Personnel), Dave, A. (Key Personnel), Goel, S. (Key Personnel), Lador, A. (Key Personnel), Mathuria, N. (Key Personnel), Nagueh, S. (Key Personnel), Schurmann, P. A. (Key Personnel) & Shah, D. J. (Key Personnel)

  Project: Clinical Trial

• TRILUMINATE Pivotal Trial

  Little, S. H. (PI), Ahsan, S. A. (Key Personnel), Chang, S.-M. (Key Personnel), Faza, N. (Key Personnel), Goel, S. (Key Personnel), Gorthi, J. R. (Key Personnel), Kassi, M. (Key Personnel), Kim, J. H. (Key Personnel), Kleiman, N. (Key Personnel), Reardon, M. J. (Key Personnel), Shah, D. J. (Key Personnel) & Yousefzai, R. (Key Personnel)

  Project: Clinical Trial

• SH-The Intrepid TMVR Pilot Study

  Kleiman, N. (PI), Faza, N. (Key Personnel), Goel, S. (Key Personnel), Little, S. H. (Key Personnel) & Reardon, M. J. (Key Personnel)

  Project: Clinical Trial

• CardOnc screening

  Bhimaraj, A. (Key Personnel), Guha, A. (Key Personnel), Niravath, P. A. (Key Personnel) & Pingali, S. R. (Key Personnel)

  Project: Clinical Trial

• PEERLESS Study

  Le, L. (Key Personnel), Peden, E. K. (Key Personnel), Rahimi, M. (Key Personnel) & Roy, T. (Key Personnel)

  Project: Clinical Trial

• Cross-Sectional Screening for Peripheral Arterial Disease in End-Stage Renal Disease Patients on Hemodialysis

  Peden, E. K. (PI)

  Project: Clinical Trial

• A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Participants With High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast

  Mai, H. P. (PI), Chang, J. C. (Key Personnel), Niravath, P. A. (Key Personnel), Sun, K. (Key Personnel) & Templeton, S. (Key Personnel)

  Project: Clinical Trial

• SH-Medtronic TAVR in Low Risk Patients

  Kleiman, N. (PI), Faza, N. (Key Personnel), Goel, S. (Key Personnel), Little, S. H. (Key Personnel) & Reardon, M. J. (Key Personnel)

  Project: Clinical Trial

• A prospective, multi-center, observational study of the safety, tolerability and effectiveness of SPINRAZA in adult patients with Spinal Muscular Atr

  Liao, B. (PI), Greene, E. P. (Key Personnel) & Shroff, S. (Key Personnel)

  Project: Clinical Trial

• KOAR - Allosure Registry

  Yi, S. (PI), Gaber, A. O. (Key Personnel), Knight, R. J. (Key Personnel) & Saharia, A. (Key Personnel)

  Project: Clinical Trial

• Diagnostic and Prognostic Changes in Oral and Gut Microbiome Composition in Patients Suffering from Acute Stroke

  Villapol, S. (PI), Britz, G. W. (Key Personnel) & Hodics, T. M. (Key Personnel)

  Project: Clinical Trial

• FAME 3

  Shah, A. R. (PI), Buergler, J. (Key Personnel), Kleiman, N. (Key Personnel) & Reardon, M. J. (Key Personnel)

  Project: Clinical Trial

• EP - TRAVERSE

  Valderrábano, M. (PI), Dave, A. (Key Personnel), Fung, S. H. (Key Personnel), Lador, A. (Key Personnel), Mathuria, N. (Key Personnel) & Schurmann, P. A. (Key Personnel)

  Project: Clinical Trial

• A randomized double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease (VICTORION-2 PREVENT)

  Volpi, J. J. (PI), Chang, S.-M. (Key Personnel), Chiu, D. (Key Personnel), Gadhia, R. R. (Key Personnel), Garg, T. (Key Personnel), Hodics, T. M. (Key Personnel) & Misra, V. (Key Personnel)

  Project: Clinical Trial

• Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma

  Ganguly, S. (PI), Mai, H. P. (Key Personnel), Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)

  Project: Clinical Trial

• The Impact of Weight Reduction on Coronary Microvascular Function and Cardiac and Microvascular Structure and Function

  Al Rifai, M. S. (PI), Al-Mallah, M. (Key Personnel), Lee, A. G. (Key Personnel), Nagueh, S. (Key Personnel), Nasir, K. (Key Personnel) & Tariq, N. (Key Personnel)

  Project: Clinical Trial

• Finished

  Task C14 Option 2, Non-Traditional and Animal Replacement Models of Infectious Diseases

  Nichols, J. (PI)

  7/12/24 → 1/13/25

  Project: Federal Funding Agencies

• Artificial Intelligence Tool to Optimize Organ Transplantation Outcomes (Transplant-AI)

  Waterman, A. D. (PI)

  5/15/24 → 10/31/24

  Project: Federal Funding Agencies

• Advancing Human Lung Microphysiological Systems to Model Coronavirus Infection and Test Candidate Countermeasures

  Nichols, J. (PI)

  4/12/24 → 1/17/25

  Project: Federal Funding Agencies

• Administrative Supplement to Existing NIH Grant-Purchase of a Equipment

  Pichumani, K. (PI)

  4/1/24 → 8/31/24

  Project: Federal Funding Agencies

• Evaluation of therapeutic compounds in a Helicobacter pylori - mice gastric infection model

  Mylonakis, E. (PI)

  4/1/24 → 11/30/24

  Project: Non Profit

• Impact of Irreversible T Cell Dysfunction on Transplant Outcomes

  Chen, W. (PI)

  1/12/24 → 12/31/24

  Project: Federal Funding Agencies

• Breast Cancer Screening & Diagnostics for Black Individuals in the Houston Area (Susan G. Komen)

  Chang, J. C. (PI)

  1/1/24 → 12/31/24

  Project: Non Profit

• Dissecting the role of the mTOR pathway in tumor persistence

  Li, Y. (PI)

  1/1/24 → 1/31/24

  Project: Non Profit

• Modulation of chromatin dynamics to promote transplant survival

  Li, X. C. (PI)

  12/6/23 → 10/31/24

  Project: Federal Funding Agencies

• The Use of a Wearable Device to Assess Gait During Walking

  Lambert, B. (PI)

  10/1/23 → 7/31/24

  Project: Federal Funding Agencies

• Health System Outreach to Eliminate Disparities in Living Kidney Transplants

  Shafi, T. (PI)

  9/1/23 → 8/31/24

  Project: Federal Funding Agencies

• Sexual Assault Nurse Examiner (SANE) expansion, Houston Methodist Willowbrook

  9/1/23 → 8/31/24

  Project: State

• Metabolism and Epigenetic Regulation are Couples in Transdifferentiation and Vascular Regeneration

  Lai, L. (PI)

  9/1/23 → 8/31/24

  Project: Federal Funding Agencies

• De-labeling Penicillin Allergy in an Academic Medical Center ? A Quality Improvement Initiative

  Motazedi, T. (PI)

  9/1/23 → 12/31/24

  Project: Non Profit

• Study will be to assess safety and efficacy of adding high-intensity atorvastatin therapy to CAR-T.

  9/1/23 → 8/31/24

  Project: Federal Funding Agencies

• Development of stable mRNA cancer vaccines using RNA-plex biotechnology

  9/1/23 → 8/31/24

  Project: State

• Sexual Assault Nurse Examiner (SANE) expansion, Houston Methodist West

  9/1/23 → 8/31/24

  Project: State

• Development of a computational platform to streamline neoantigen selection

  9/1/23 → 8/31/24

  Project: State

• Precision targeting of immunogens: Creation of HLA strains

  Gollihar, J. D. (PI)

  9/1/23 → 8/31/24

  Project: State